SI2001900T1 - Novi izolirani in očiščeni sevi chikunguny-a virusa in polinukleotidi in polipeptidna zaporedja, diagnostika in imunogenska uporaba le-teh - Google Patents

Novi izolirani in očiščeni sevi chikunguny-a virusa in polinukleotidi in polipeptidna zaporedja, diagnostika in imunogenska uporaba le-teh

Info

Publication number
SI2001900T1
SI2001900T1 SI200731678T SI200731678T SI2001900T1 SI 2001900 T1 SI2001900 T1 SI 2001900T1 SI 200731678 T SI200731678 T SI 200731678T SI 200731678 T SI200731678 T SI 200731678T SI 2001900 T1 SI2001900 T1 SI 2001900T1
Authority
SI
Slovenia
Prior art keywords
immunogenical
polynucleotides
diagnostic
chikungunya virus
novel isolated
Prior art date
Application number
SI200731678T
Other languages
English (en)
Slovenian (sl)
Inventor
Philippe Despres
Anne-Claire Brehin
Valerie Marechal
Pierre Charneau
Philippe Souque
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002538898A external-priority patent/CA2538898A1/fr
Application filed by Institut Pasteur filed Critical Institut Pasteur
Publication of SI2001900T1 publication Critical patent/SI2001900T1/sl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/116—Togaviridae (F); Matonaviridae (F); Flaviviridae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36131—Uses of virus other than therapeutic or vaccine, e.g. disinfectant
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G01N2333/181—Alphaviruses or Group A arboviruses, e.g. sindbis, VEE, EEE, WEE or semliki forest virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
SI200731678T 2006-03-15 2007-03-15 Novi izolirani in očiščeni sevi chikunguny-a virusa in polinukleotidi in polipeptidna zaporedja, diagnostika in imunogenska uporaba le-teh SI2001900T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CA002538898A CA2538898A1 (fr) 2006-03-15 2006-03-15 Nouvelles souches isolees et purifiees du virus chikungunya et sequences nucleotidiques et peptidiques, applications diagnostiques et immunogeniques
CA 2545597 CA2545597A1 (en) 2006-03-15 2006-04-04 Novel isolated and purified strains of chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof
EP07734896.9A EP2001900B1 (en) 2006-03-15 2007-03-15 Novel isolated and purified strains of chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof
PCT/IB2007/001716 WO2007105111A2 (en) 2006-03-15 2007-03-15 Novel isolated and purified strains of chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof

Publications (1)

Publication Number Publication Date
SI2001900T1 true SI2001900T1 (sl) 2015-09-30

Family

ID=38481184

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200731678T SI2001900T1 (sl) 2006-03-15 2007-03-15 Novi izolirani in očiščeni sevi chikunguny-a virusa in polinukleotidi in polipeptidna zaporedja, diagnostika in imunogenska uporaba le-teh

Country Status (12)

Country Link
US (2) US20100055105A1 (https=)
EP (2) EP2460822A3 (https=)
JP (2) JP5923232B2 (https=)
AU (1) AU2007226231B2 (https=)
CA (2) CA2545597A1 (https=)
DK (1) DK2001900T3 (https=)
ES (1) ES2543839T3 (https=)
HU (1) HUE025076T2 (https=)
PL (1) PL2001900T3 (https=)
PT (1) PT2001900E (https=)
SI (1) SI2001900T1 (https=)
WO (1) WO2007105111A2 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2545597A1 (en) * 2006-03-15 2007-09-15 Institut Pasteur Novel isolated and purified strains of chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof
CN101516395B (zh) * 2006-09-01 2014-03-26 伯哈拉特生物技术国际有限公司 抗屈曲病毒感染的疫苗
CA2598966A1 (en) * 2007-09-07 2009-03-07 Institut Pasteur Anti-chikungunya monoclonal antibodies and uses thereof
FR2921064A1 (fr) * 2007-09-14 2009-03-20 Biomerieux Sa Oligonucleotides, utilisation, methode de detection et kit permettant de diagnostiquer la presence du gene e1 du virus du chikungunya
CA2720166A1 (en) * 2008-04-04 2009-10-08 David B. Weiner Consensus sequences of chikungunya viral proteins, nucleic acid molecules encoding the same, and compositions and methods for using the same
EP3957754B1 (en) * 2008-04-21 2026-01-28 Gen-Probe Incorporated Method for detecting chikungunya virus
CN102414217A (zh) * 2009-02-25 2012-04-11 彼格泰格私人有限公司 用于检测基孔肯雅病毒的探针和引物
WO2012078116A1 (en) * 2010-12-10 2012-06-14 Agency For Science, Technology And Research Immunogenic chikungunya virus peptides
WO2012131580A1 (en) * 2011-03-28 2012-10-04 Scms, Institute Of Bioscience And Biotechnology Research And Development Method of detecting chikungunya virus utilizing a recombinant el coat peptide antigen
EP2712871A1 (en) * 2012-09-27 2014-04-02 Institut Pasteur Recombinant Measles virus expressing Chikungunya virus polypeptides and their applications
BR112015006840A2 (pt) * 2012-09-27 2017-11-21 Res Found Dev vírus chikungunya atenuado
JP6903120B2 (ja) * 2016-07-15 2021-07-14 エトゥビクス コーポレーション アルファウイルスワクチン接種のための組成物及び方法
TW202300515A (zh) 2016-10-20 2023-01-01 法商賽諾菲公司 抗ｃｈｉｋｖ抗體及其用途
JP7301811B2 (ja) * 2017-09-21 2023-07-03 ヴァルネヴァ エスイー 免疫原性チクングニアウイルスｃｈｉｋｖ－ｄｅｌｔａ ５ｎｓｐ３を含む医薬組成物を製造する方法
WO2020069054A1 (en) * 2018-09-27 2020-04-02 Texas Tech University System Stable cell line secreting chikungunya virus (chikv) virus like particles (vlp) for vaccines
US20230398200A1 (en) * 2020-07-31 2023-12-14 Replicate Bioscience, Inc. Modified chikungunya viruses and sindbis viruses and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100233209A1 (en) * 2005-08-11 2010-09-16 Higgs Stephen T Chikungunya virus infectious clones and uses therefor
CA2545597A1 (en) * 2006-03-15 2007-09-15 Institut Pasteur Novel isolated and purified strains of chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof
CN101516395B (zh) * 2006-09-01 2014-03-26 伯哈拉特生物技术国际有限公司 抗屈曲病毒感染的疫苗

Also Published As

Publication number Publication date
US9442114B2 (en) 2016-09-13
PT2001900E (pt) 2015-09-15
WO2007105111A2 (en) 2007-09-20
DK2001900T3 (en) 2015-07-27
EP2460822A3 (en) 2012-09-26
US20150111197A1 (en) 2015-04-23
EP2460822A2 (en) 2012-06-06
CA2646520A1 (en) 2007-09-20
HUE025076T2 (en) 2016-02-29
EP2001900B1 (en) 2015-04-29
JP2013126414A (ja) 2013-06-27
JP6104584B2 (ja) 2017-03-29
JP2009529868A (ja) 2009-08-27
CA2545597A1 (en) 2007-09-15
CA2646520C (en) 2018-05-15
AU2007226231B2 (en) 2013-07-11
JP5923232B2 (ja) 2016-05-24
PL2001900T3 (pl) 2015-10-30
AU2007226231A1 (en) 2007-09-20
WO2007105111A3 (en) 2008-03-27
ES2543839T3 (es) 2015-08-24
EP2001900A2 (en) 2008-12-17
US20100055105A1 (en) 2010-03-04

Similar Documents

Publication Publication Date Title
SI2001900T1 (sl) Novi izolirani in očiščeni sevi chikunguny-a virusa in polinukleotidi in polipeptidna zaporedja, diagnostika in imunogenska uporaba le-teh
EP1937702A4 (en) NUCLEOTIDE ANALOGUES LABELS AND USES THEREOF
GB0712670D0 (en) Isolated peptides and uses thereof
AP2519A (en) Nucleotide sequences encoding insecticidal proteins
WO2006133089A3 (en) Improved human interferon molecules and their uses
WO2011041499A3 (en) Isolated rice lp2 promoter and uses thereof
IL196292A0 (en) Csf3r polypeptides, their preparation and uses thereof
IL172297A0 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis iii
PL2221383T3 (pl) Sekwencja nukleotydowa kodująca polipeptyd przeciwgrzybiczy
GB0505975D0 (en) Novel use of peptide
EP2197899B8 (fr) Peptides cycliques comprenant au moins un residu aza-beta-3 aminoacycle et leurs utilisations
ZA201200046B (en) Therapeutic peptides, polypeptides and nucleic acid sequences
ZA201006443B (en) Novel immunoregularory peptides,compositions and uses thereof
WO2007144492A3 (fr) Peptides a activite anti-proliferative
GB0803826D0 (en) Novel therapeutic agent derived from marine organism
EP1954826A4 (en) NEW NUCLEOTIDE AND AMINO ACID SEQUENCES AND TESTS AND METHOD FOR THEIR USE FOR DIAGNOSIS
WO2006122650A3 (de) Isoliertes photoprotein aqdecay sowie dessen verwendung
IL174465A0 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
EP1910405A4 (en) PEPTIDES DERIVED FROM COMPLEMENT C3A AND APPLICATIONS THEREOF
AU2006906256A0 (en) Cyclic peptides and uses thereof
AU2007906371A0 (en) Cyclic peptides and uses thereof
GB2464028B (en) An isolated fibrillar structure protein of the foot-and-mouth disease virus and uses thereof
GB0921328D0 (en) Therapeutic peptides, polypeptides and nucleic acid sequences
AU2005901631A0 (en) Genetic sequences and uses therefor
IL187520A0 (en) COMPLEMENT C3a DERIVED PEPTIDES AND USES THEREOF